Search - tctmd.com

Displaying 301 - 320 of 39119

Sort: Relevancy | Date

Presentation THT 2026

Effect of Cardiac Contractility Modulation (CCM) Therapy on Reverse Remodeling in Heart Failure Patients with Left Ventricular Ejection Fraction 25-45%

Presenter: Rami Kahwash

March 02, 2026

Presentation THT 2026

Relationship Between Remote, Ambulatory Pulmonary Artery Pressures, and the Risk of Heart Failure Hospitalizations in Patients With Chronic Heart Failure

Presenter: Michael R. Zile

March 02, 2026

Presentation THT 2026

Prospective Validation of the STOPSHOCK Score for Early Cardiogenic Shock Prediction in Acute Coronary Syndrome: A Real-World Perspective

Presenter: Allan Böhm

March 02, 2026

Presentation THT 2026

Initial Six-Month Outcomes With Baroreflex Activation Therapy From the REBALANCE Registry

Presenter: Dmitry Yaranov

March 02, 2026

Presentation THT Abstracts 2026

SGLT2 Inhibitor Outcomes In Adult Congenital Heart Disease: A Retrospective Cohort Study

Presenter: Shaival Sharma

March 02, 2026

Presentation THT Abstracts 2026

Baseline NT-proBNP Predicts Outcomes After Transcatheter Edge-to-Edge Repair for Secondary Mitral Regurgitation with Preserved Ejection Fraction: The REPAIR Study

Presenter: Philipp von Stein

March 02, 2026

Presentation THT Abstracts 2026

Examining Etiologies of Mortality in the Context of Real World Multidisciplinary Shock Team

Presenter: Marcos Molina

March 02, 2026

Presentation THT Abstracts 2026

Impact of Baroreflex Activation Therapy on Hospitalizations: A Single Center Retrospective analysis

Presenter: Joel Joseph

March 02, 2026

Presentation THT Abstracts 2026

Hemodynamic and Functional Impact of Coronary Sinus Reducer Versus Enhanced External Counterpulsation in Chronic Ischemic Heart Failure

Presenter: Nayana Bhandari

March 02, 2026

Presentation THT Abstracts 2026

When Vigilance Requires a Catheter: Evaluating the Challenges of Vigileo Monitoring Versus Invasive Hemodynamics in Cardiogenic Shock in a Community Setting

Presenter: Aladin Altic

March 02, 2026

Presentation THT 2026

Autologous Cell Therapy May Curb Pathological Ventricular Remodeling in Chronic Ischemic HFrEF Patients Selected for Favorable Cell Characteristics - Late Breaking Echocardiography Results from the CardiAMP HF trial

Presenter: Amish Raval

March 02, 2026

Presentation THT Abstracts 2026

Non-Invasive Venous Waveform Analysis (NIVA) Scores Obtained with NIVAHF Demonstrate Agreement with Pulmonary Capillary Wedge Pressure (PCWP) Measurements in Patients Undergoing Right Heart Catheterization: A Multi-Site Study

Presenter: Bret Alvis

March 02, 2026

Presentation THT Abstracts 2026

Outcomes and Risk Factors Among Hospitalizations Requiring Temporary Mechanical Circulatory Support for Cardiogenic Shock

Presenter: Omaima Chaudhary

March 02, 2026

Presentation THT Abstracts 2026

Outcomes of Left Atrial Appendage Occlusion With the Watchman Device in Patients With Hypertrophic Cardiomyopathy

Presenter: Vijayadithyan Jaganathan

March 02, 2026

Presentation THT Abstracts 2026

Outcomes of Transcatheter Versus Surgical Aortic Valve Replacement in Cardiogenic Shock

Presenter: Omaima Chaudhary

March 02, 2026

Presentation THT Abstracts 2026

Persistent elevation of donor-derived cell-free DNA in simultaneous heart-kidney recipients: signal or noise?

Presenter: Anish Kanesa-thasan

March 02, 2026

Presentation THT Abstracts 2026

Persistently Elevated Donor-Derived Cell-Free DNA After Heart Transplant: A Clinical Dilemma

Presenter: David Golombeck

March 02, 2026

Presentation THT Abstracts 2026

Potassium Levels and In-Hospital Mortality in Acute Heart Failure

Presenter: Aarjuv Majmundar

March 02, 2026

Presentation THT Abstracts 2026

Practice Patterns of Discharge Medical Therapy after Acute Takotsubo Syndrome

Presenter: Rohan Ganti

March 02, 2026

Presentation THT Abstracts 2026

Real-World Association of SGLT2 Inhibitors With Survival and Arrhythmic Risk in Advanced Cardio-Renal Disease

Presenter: Mazen Ahmed

March 02, 2026

Advertisement

Effect of Cardiac Contractility Modulation (CCM) Therapy on Reverse Remodeling in Heart Failure Patients with Left Ventricular Ejection Fraction 25-45%

Relationship Between Remote, Ambulatory Pulmonary Artery Pressures, and the Risk of Heart Failure Hospitalizations in Patients With Chronic Heart Failure

Prospective Validation of the STOPSHOCK Score for Early Cardiogenic Shock Prediction in Acute Coronary Syndrome: A Real-World Perspective

Initial Six-Month Outcomes With Baroreflex Activation Therapy From the REBALANCE Registry

SGLT2 Inhibitor Outcomes In Adult Congenital Heart Disease: A Retrospective Cohort Study

Baseline NT-proBNP Predicts Outcomes After Transcatheter Edge-to-Edge Repair for Secondary Mitral Regurgitation with Preserved Ejection Fraction: The REPAIR Study

Examining Etiologies of Mortality in the Context of Real World Multidisciplinary Shock Team

Impact of Baroreflex Activation Therapy on Hospitalizations: A Single Center Retrospective analysis

Hemodynamic and Functional Impact of Coronary Sinus Reducer Versus Enhanced External Counterpulsation in Chronic Ischemic Heart Failure

When Vigilance Requires a Catheter: Evaluating the Challenges of Vigileo Monitoring Versus Invasive Hemodynamics in Cardiogenic Shock in a Community Setting

Autologous Cell Therapy May Curb Pathological Ventricular Remodeling in Chronic Ischemic HFrEF Patients Selected for Favorable Cell Characteristics - Late Breaking Echocardiography Results from the CardiAMP HF trial

Non-Invasive Venous Waveform Analysis (NIVA) Scores Obtained with NIVAHF Demonstrate Agreement with Pulmonary Capillary Wedge Pressure (PCWP) Measurements in Patients Undergoing Right Heart Catheterization: A Multi-Site Study

Outcomes and Risk Factors Among Hospitalizations Requiring Temporary Mechanical Circulatory Support for Cardiogenic Shock

Outcomes of Left Atrial Appendage Occlusion With the Watchman Device in Patients With Hypertrophic Cardiomyopathy

Outcomes of Transcatheter Versus Surgical Aortic Valve Replacement in Cardiogenic Shock

Persistent elevation of donor-derived cell-free DNA in simultaneous heart-kidney recipients: signal or noise?

Persistently Elevated Donor-Derived Cell-Free DNA After Heart Transplant: A Clinical Dilemma

Potassium Levels and In-Hospital Mortality in Acute Heart Failure

Practice Patterns of Discharge Medical Therapy after Acute Takotsubo Syndrome

Real-World Association of SGLT2 Inhibitors With Survival and Arrhythmic Risk in Advanced Cardio-Renal Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content